Linkage of microRNA and proteome-based profiling data sets: A perspective for the priorization of candidate biomarkers in renal cell carcinoma?

Journal of Proteome Research

Volumn 10, Issue 1, 2011, Pages 191-199

  Seliger, Barbara ^a,b   Jasinski, Simon ^a,b   Dressler, Sven P ^a,b   Marincola, Francesco M ^a,b   Recktenwald, Christian V ^a,b,c   Wang, Ena ^a,b,c   Lichtenfels, Rudolf ^a,b,c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b CLINICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Biomarker; miR; Proteomics; RCC

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; PROTEOME; TUMOR MARKER;

EVALUATION; HIGH THROUGHPUT SCREENING; HUMAN; KIDNEY CARCINOMA; KIDNEY EPITHELIUM; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REVIEW; SCORING SYSTEM; VALIDATION PROCESS;

CARCINOMA, RENAL CELL; DATABASES, GENETIC; HUMANS; KIDNEY NEOPLASMS; MICRORNAS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 79951546516     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr1011137     Document Type: Review

References (104)

1. Ljungberg, B.; Hanbury, D. C.; Kuczyk, M. A.; Merseburger, A. S.; Mulders, P. F.; Patard, J. J.; Sinescu, I. C. Renal cell carcinoma guideline. Eur. Urol. 2007, 51 (6), 1502-10. (Pubitemid 46634775)
2. Campbell, D.; Walker, R.; Mathew, T.; Craig, J. Commentary on Influence of industry on renal guideline development. Clin. J. Am. Soc. Nephrol. 2007, 2 (2), 211.
3. Yoshimoto, T.; Matsuura, K.; Karnan, S.; Tagawa, H.; Nakada, C.; Tanigawa, M.; Tsukamoto, Y.; Uchida, T.; Kashima, K.; Akizuki, S.; Takeuchi, I.; Sato, F.; Mimata, H.; Seto, M.; Moriyama, M. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. J. Pathol. 2007, 213 (4), 392-401. (Pubitemid 350206511)
4. Lam, J. S.; Leppert, J. T.; Belldegrun, A. S.; Figlin, R. A. Novel approaches in the therapy of metastatic renal cell carcinoma. World J. Urol. 2005, 23 (3), 202-12. (Pubitemid 41136043)
5. Fuhrman, S. A.; Lasky, L. C.; Limas, C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 1982, 6 (7), 655-63. (Pubitemid 13234762)
6. Janzen, N. K.; Kim, H. L.; Figlin, R. A.; Belldegrun, A. S. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol. Clin. North Am. 2003, 30 (4), 843-52. (Pubitemid 37485197)
7. Ficarra, V.; Guille, F.; Schips, L.; de la Taille, A.; Prayer Galetti, T.; Tostain, J.; Cindolo, L.; Novara, G.; Zigeuner, R.; Bratti, E.; Li, G.; Altieri, V.; Abbou, C. C.; Zanolla, L.; Artibani, W.; Patard, J. J. Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer 2005, 104 (10), 2116-23. (Pubitemid 41579957)
8. FDA. FDA Clears Breast Cancer Specific Molecular Prognostic Test, 2007; http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108836.htm (last accessed 12/ 15/10).
9. Fan, X.; Shi, L.; Fang, H.; Cheng, Y.; Perkins, R.; Tong, W. DNA microarrays are predictive of cancer prognosis: a re-evaluation. Clin. Cancer Res. 2010, 16 (2), 629-36.
10. Osunkoya, A. O.; Yin-Goen, Q.; Phan, J. H.; Moffitt, R. A.; Stokes, T. H.; Wang, M. D.; Young, A. N. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis. Hum. Pathol. 2009, 40 (12), 1671-8.
11. Ohno, Y.; Izumi, M.; Tachibana, M.; Kawamura, T.; Yoshioka, K.; Aoyagi, T.; Ohori, M.; Namiki, K.; Sakamoto, N.; Nakagami, Y.; Hatano, T.; Akimoto, S.; Nishimura, T. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines. Oncol. Rep. 2008, 20 (3), 501-9.
12. Liu, C. G.; Calin, G. A.; Meloon, B.; Gamliel, N.; Sevignani, C.; Ferracin, M.; Dumitru, C. D.; Shimizu, M.; Zupo, S.; Dono, M.; Alder, H.; Bullrich, F.; Negrini, M.; Croce, C. M. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (26), 9740-4. (Pubitemid 38869306)
13. Engels, B. M.; Hutvagner, G. Principles and effects of microRNAmediated post-transcriptional gene regulation. Oncogene 2006, 25 (46), 6163-9. (Pubitemid 44527846)
14. Zeng, Y.; Cullen, B. R. Recognition and cleavage of primary microRNA transcripts. Methods Mol. Biol. 2006, 342, 49-56.
15. Cheng, J.; Zhou, L.; Xie, Q. F.; Xie, H. Y.; Wei, X. Y.; Gao, F.; Xing, C. Y.; Xu, X.; Li, L. J.; Zheng, S. S. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells. Proteomics 2010, 10 (8), 1557-72.
16. Vasudevan, S.; Tong, Y.; Steitz, J. A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318 (5858), 1931-4.
17. Yang, Y.; Chaerkady, R.; Beer, M. A.; Mendell, J. T.; Pandey, A. Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach. Proteomics 2009, 9 (5), 1374-84.
18. Esquela-Kerscher, A.; Slack, F. J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6 (4), 259-69.
19. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116 (2), 281-97.
20. Ambros, V. The functions of animal microRNAs. Nature 2004, 431 (7006), 350-5. (Pubitemid 39265675)
21. Gottardo, F.; Liu, C. G.; Ferracin, M.; Calin, G. A.; Fassan, M.; Bassi, P.; Sevignani, C.; Byrne, D.; Negrini, M.; Pagano, F.; Gomella, L. G.; Croce, C. M.; Baffa, R. Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 2007, 25 (5), 387-92. (Pubitemid 47362758)
22. Huang, Y.; Dai, Y.; Yang, J.; Chen, T.; Yin, Y.; Tang, M.; Hu, C.; Zhang, L. Microarray analysis of microRNA expression in renal clear cell carcinoma. Eur. J. Surg. Oncol. 2009, 35 (10), 1119-23.
23. Jung, M.; Mollenkopf, H. J.; Grimm, C.; Wagner, I.; Albrecht, M.; Waller, T.; Pilarsky, C.; Johannsen, M.; Stephan, C.; Lehrach, H.; Nietfeld, W.; Rudel, T.; Jung, K.; Kristiansen, G. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J. Cell. Mol. Med. 2009, 13 (9B), 3918-28.
24. Lu, J.; Getz, G.; Miska, E. A.; Alvarez-Saavedra, E.; Lamb, J.; Peck, D.; Sweet-Cordero, A.; Ebert, B. L.; Mak, R. H.; Ferrando, A. A.; Downing, J. R.; Jacks, T.; Horvitz, H. R.; Golub, T. R. MicroRNA expression profiles classify human cancers. Nature 2005, 435 (7043), 834-8. (Pubitemid 40839735)
25. Petillo, D.; Kort, E. J.; Anema, J.; Furge, K. A.; Yang, X. J.; Teh, B. T. MicroRNA profiling of human kidney cancer subtypes. Int. J. Oncol. 2009, 35 (1), 109-14.
26. Liu, H.; Brannon, A. R.; Reddy, A. R.; Alexe, G.; Seiler, M. W.; Arreola, A.; Oza, J. H.; Yao, M.; Juan, D.; Liou, L. S.; Ganesan, S.; Levine, A. J.; Rathmell, W.; Bhanot, G. V. Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Syst. Biol. 2010, 4, 51.
27. Calin, G. A.; Sevignani, C.; Dumitru, C. D.; Hyslop, T.; Noch, E.; Yendamuri, S.; Shimizu, M.; Rattan, S.; Bullrich, F.; Negrini, M.; Croce, C. M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (9), 2999-3004. (Pubitemid 38327724)
28. Jiang, J.; Lee, E. J.; Gusev, Y.; Schmittgen, T. D. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res. 2005, 33 (17), 5394-403. (Pubitemid 41548806)
29. Biscontin, A.; Casara, S.; Cagnin, S.; Tombolan, L.; Rosolen, A.; Lanfranchi, G.; De Pitta, C. New miRNA labeling method for beadbased quantification. BMC Mol. Biol. 2010, 11, 44.
30. Morin, R. D.; Aksay, G.; Dolgosheina, E.; Ebhardt, H. A.; Magrini, V.; Mardis, E. R.; Sahinalp, S. C.; Unrau, P. J. Comparative analysis of the small RNA transcriptomes of Pinus contorta and Oryza sativa. Genome Res. 2008, 18 (4), 571-84. (Pubitemid 351482782)
31. Rajagopalan, R.; Vaucheret, H.; Trejo, J.; Bartel, D. P. A diverse and evolutionarily fluid set of microRNAs in Arabidopsis thaliana. Genes Dev. 2006, 20 (24), 3407-25. (Pubitemid 44969159)
32. Kasschau, K. D.; Fahlgren, N.; Chapman, E. J.; Sullivan, C. M.; Cumbie, J. S.; Givan, S. A.; Carrington, J. C. Genome-wide profiling and analysis of Arabidopsis siRNAs. PLoS Biol. 2007, 5 (3), e57.
33. Lu, Y. C.; Smielewska, M.; Palakodeti, D.; Lovci, M. T.; Aigner, S.; Yeo, G. W.; Graveley, B. R. Deep sequencing identifies new and regulated microRNAs in Schmidtea mediterranea. RNA 2009, 15 (8), 1483-91.
34. Moxon, S.; Jing, R.; Szittya, G.; Schwach, F.; Rusholme Pilcher, R. L.; Moulton, V.; Dalmay, T. Deep sequencing of tomato short RNAs identifies microRNAs targeting genes involved in fruit ripening. Genome Res. 2008, 18 (10), 1602-9.
35. Weng, L.; Wu, X.; Gao, H.; Mu, B.; Li, X.; Wang, J. H.; Guo, C.; Jin, J. M.; Chen, Z.; Covarrubias, M.; Yuan, Y. C.; Weiss, L. M.; Wu, H. MicroRNA profiling of clear cell renal cell carcinoma by wholegenome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J. Pathol. 2010, 222 (1), 41-51.
36. Tam, W. The emergent role of microRNAs in molecular diagnostics of cancer. J. Mol. Diagn. 2008, 10 (5), 411-4.
37. Miranda, K. C.; Huynh, T.; Tay, Y.; Ang, Y. S.; Tam, W. L.; Thomson, A. M.; Lim, B.; Rigoutsos, I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006, 126 (6), 1203-17. (Pubitemid 44380294)
38. John, B.; Enright, A. J.; Aravin, A.; Tuschl, T.; Sander, C.; Marks, D. S. Human MicroRNA targets. PLoS Biol. 2004, 2 (11), e363.
39. Wang, X. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 2008, 14 (6), 1012-7.
40. Lewis, B. P.; Burge, C. B.; Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120 (1), 15-20. (Pubitemid 40094598)
41. Kruger, J.; Rehmsmeier, M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 2006, 34 (Web Server issue), W451-4. (Pubitemid 44529811)
42. Kertesz, M.; Iovino, N.; Unnerstall, U.; Gaul, U.; Segal, E. The role of site accessibility in microRNA target recognition. Nat. Genet. 2007, 39 (10), 1278-84. (Pubitemid 47482690)
43. Krek, A.; Grun, D.; Poy, M. N.; Wolf, R.; Rosenberg, L.; Epstein, E. J.; MacMenamin, P.; da Piedade, I.; Gunsalus, K. C.; Stoffel, M.; Rajewsky, N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37 (5), 495-500. (Pubitemid 40617277)
44. Maragkakis, M.; Alexiou, P.; Papadopoulos, G. L.; Reczko, M.; Dalamagas, T.; Giannopoulos, G.; Goumas, G.; Koukis, E.; Kourtis, K.; Simossis, V. A.; Sethupathy, P.; Vergoulis, T.; Koziris, N.; Sellis, T.; Tsanakas, P.; Hatzigeorgiou, A. G. Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinform. 2009, 10, 295.
45. Baek, D.; Villen, J.; Shin, C.; Camargo, F. D.; Gygi, S. P.; Bartel, D. P. The impact of microRNAs on protein output. Nature 2008, 455 (7209), 64-71.
46. Ma, L.; Weinberg, R. A. Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet. 2008, 24 (9), 448-56.
47. Dykxhoorn, D. M. MicroRNAs and Metastasis: Little RNAs Go a Long Way. Cancer Res. 2010, 70 (16), 6401-6.
48. Varol, N.; Konac, E.; Gurocak, O. S.; Sozen, S. The realm of microRNAs in cancers. Mol. Biol. Rep. 2010, DOI: 10.1007/s11033- 010-0205-0.
49. He, L.; Thomson, J. M.; Hemann, M. T.; Hernando-Monge, E.; Mu, D.; Goodson, S.; Powers, S.; Cordon-Cardo, C.; Lowe, S. W.; Hannon, G. J.; Hammond, S. M. A microRNA polycistron as a potential human oncogene. Nature 2005, 435 (7043), 828-33. (Pubitemid 40839734)
50. Hammond, S. M. MicroRNA therapeutics: a new niche for antisense nucleic acids. Trends Mol. Med. 2006, 12 (3), 99-101.
51. Ortholan, C.; Puissegur, M. P.; Ilie, M.; Barbry, P.; Mari, B.; Hofman, P. MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Curr. Med. Chem. 2009, 16 (9), 1047-61.
52. Iwai, N.; Naraba, H. Polymorphisms in human pre-miRNAs. Biochem. Biophys. Res. Commun. 2005, 331 (4), 1439-44. (Pubitemid 40692516)
53. Kanwar, J. R.; Mahidhara, G.; Kanwar, R. K. MicroRNA in human cancer and chronic inflammatory diseases. Front. Biosci. (Schol. Ed.) 2010, 2, 1113-26.
54. Hildebrandt, M. A.; Gu, J.; Lin, J.; Ye, Y.; Tan, W.; Tamboli, P.; Wood, C. G.; Wu, X. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 2010, 29 (42), 5724-8.
55. Horikawa, Y.; Wood, C. G.; Yang, H.; Zhao, H.; Ye, Y.; Gu, J.; Lin, J.; Habuchi, T.; Wu, X. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin. Cancer Res. 2008, 14 (23), 7956-62.
56. Yi, Z.; Fu, Y.; Zhao, S.; Zhang, X.; Ma, C. Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. J. Cancer Res. Clin. Oncol. 2010, 136 (6), 855-62.
57. Chow, T. F.; Youssef, Y. M.; Lianidou, E.; Romaschin, A. D.; Honey, R. J.; Stewart, R.; Pace, K. T.; Yousef, G. M. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin. Biochem. 2010, 43 (1-2), 150-8.
58. Juan, D.; Alexe, G.; Antes, T.; Liu, H.; Madabhushi, A.; Delisi, C.; Ganesan, S.; Bhanot, G.; Liou, L. S. Identification of a microRNA panel for clear-cell kidney cancer. Urology 2010, 75 (4), 835-41.
59. White, N. M.; Bui, A.; Mejia-Guerrero, S.; Chao, J.; Soosaipillai, A.; Youssef, Y.; Mankaruos, M.; Honey, R. J.; Stewart, R.; Pace, K. T.; Sugar, L.; Diamandis, E. P.; Dore, J.; Yousef, G. M. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs. Biol. Chem. 2010, 391 (4), 411-23.
60. Slaby, O.; Jancovicova, J.; Lakomy, R.; Svoboda, M.; Poprach, A.; Fabian, P.; Kren, L.; Michalek, J.; Vyzula, R. Expression of miRNA- 106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J. Exp. Clin. Cancer Res. 2010, 29, 90.
61. Nakada, C.; Matsuura, K.; Tsukamoto, Y.; Tanigawa, M.; Yoshimoto, T.; Narimatsu, T.; Nguyen, L. T.; Hijiya, N.; Uchida, T.; Sato, F.; Mimata, H.; Seto, M.; Moriyama, M. Genome-wide microRNA expression profiling in renal cell carcinoma: significant downregulation of miR-141 and miR-200c. J. Pathol. 2008, 216 (4), 418-27.
62. Park, S. M.; Gaur, A. B.; Lengyel, E.; Peter, M. E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22 (7), 894-907. (Pubitemid 351482843)
63. Dutta, K. K.; Zhong, Y.; Liu, Y. T.; Yamada, T.; Akatsuka, S.; Hu, Q.; Yoshihara, M.; Ohara, H.; Takehashi, M.; Shinohara, T.; Masutani, H.; Onuki, J.; Toyokuni, S. Association of microRNA- 34a overexpression with proliferation is cell type-dependent. Cancer Sci. 2007, 98 (12), 1845-52. (Pubitemid 350002188)
64. Volinia, S.; Calin, G. A.; Liu, C. G.; Ambs, S.; Cimmino, A.; Petrocca, F.; Visone, R.; Iorio, M.; Roldo, C.; Ferracin, M.; Prueitt, R. L.; Yanaihara, N.; Lanza, G.; Scarpa, A.; Vecchione, A.; Negrini, M.; Harris, C. C.; Croce, C. M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (7), 2257-61. (Pubitemid 43271657)
65. Kallio, J. P.; Mahlamaki, E. H.; Helin, H.; Karhu, R.; Kellokumpu- Lehtinen, P.; Tammela, T. L. Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma. Scand. J. Urol. Nephrol. 2004, 38 (3), 225-30.
66. Moch, H.; Presti, J. C., Jr.; Sauter, G.; Buchholz, N.; Jordan, P.; Mihatsch, M. J.; Waldman, F. M. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res. 1996, 56 (1), 27-30. (Pubitemid 26010380)
67. Slaby, O.; Jancovicova, J.; Lakomy, R.; Svoboda, M.; Poprach, A.; Fabian, P.; Kren, L.; Michalek, J.; Vyzula, R. Correction: Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J. Exp. Clin. Cancer Res. 2010, 29 (1), 105.
68. Seliger, B.; Dressler, S. P.; Wang, E.; Kellner, R.; Recktenwald, C. V.; Lottspeich, F.; Marincola, F. M.; Baumgartner, M.; Atkins, D.; Lichtenfels, R. Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma. Proteomics 2009, 9 (6), 1567-81.
69. Seliger, B.; Menig, M.; Lichtenfels, R.; Atkins, D.; Bukur, J.; Halder, T. M.; Kersten, M.; Harder, A.; Ackermann, A.; Beck, J.; Muehlenweg, B.; Brenner, W.; Melchior, S.; Kellner, R.; Lottspeich, F. Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy. Proteomics 2003, 3 (6), 979-90. (Pubitemid 36801686)
70. Sarto, C.; Frutiger, S.; Cappellano, F.; Sanchez, J. C.; Doro, G.; Catanzaro, F.; Hughes, G. J.; Hochstrasser, D. F.; Mocarelli, P. Modified expression of plasma glutathione peroxidase and manganese superoxide dismutase in human renal cell carcinoma. Electrophoresis 1999, 20 (17), 3458-66.
71. Lichtenfels, R.; Kellner, R.; Bukur, J.; Beck, J.; Brenner, W.; Ackermann, A.; Seliger, B. Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma. Proteomics 2002, 2 (5), 561-70. (Pubitemid 34507346)
72. Balabanov, S.; Zimmermann, U.; Protzel, C.; Scharf, C.; Klebingat, K. J.; Walther, R. Tumour-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by twodimensional gel electrophoresis. Eur. J. Biochem. 2001, 268 (22), 5977-80. (Pubitemid 33079335)
73. Zimmermann, U.; Balabanov, S.; Giebel, J.; Teller, S.; Junker, H.; Schmoll, D.; Protzel, C.; Scharf, C.; Kleist, B.; Walther, R. Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. Cancer Lett. 2004, 209 (1), 111-8. (Pubitemid 38625750)
74. Seliger, B.; Lichtenfels, R.; Atkins, D.; Bukur, J.; Halder, T.; Kersten, M.; Harder, A.; Ackermann, A.; Malenica, B.; Brenner, W.; Zobawa, M.; Lottspeich, F. Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma. Proteomics 2005, 5 (10), 2631-40. (Pubitemid 40966490)
75. Unwin, R. D.; Craven, R. A.; Harnden, P.; Hanrahan, S.; Totty, N.; Knowles, M.; Eardley, I.; Selby, P. J.; Banks, R. E. Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 2003, 3 (8), 1620-32. (Pubitemid 37048086)
76. Dallmann, K.; Junker, H.; Balabanov, S.; Zimmermann, U.; Giebel, J.; Walther, R. Human agmatinase is diminished in the clear cell type of renal cell carcinoma. Int. J. Cancer 2004, 108 (3), 342-7. (Pubitemid 37549598)
77. Craven, R. A.; Stanley, A. J.; Hanrahan, S.; Dods, J.; Unwin, R.; Totty, N.; Harnden, P.; Eardley, I.; Selby, P. J.; Banks, R. E. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics 2006, 6 (9), 2853-64.
78. Poznanovic, S.; Wozny, W.; Schwall, G. P.; Sastri, C.; Hunzinger, C.; Stegmann, W.; Schrattenholz, A.; Buchner, A.; Gangnus, R.; Burgemeister, R.; Cahill, M. A. Differential radioactive proteomic analysis of microdissected renal cell carcinoma tissue by 54 cm isoelectric focusing in serial immobilized pH gradient gels. J. Proteome Res. 2005, 4 (6), 2117-25. (Pubitemid 41814278)
79. Craven, R. A.; Hanrahan, S.; Totty, N.; Harnden, P.; Stanley, A. J.; Maher, E. R.; Harris, A. L.; Trimble, W. S.; Selby, P. J.; Banks, R. E. Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma. Proteomics 2006, 6 (13), 3880-93. (Pubitemid 44065165)
80. Hwa, J. S.; Park, H. J.; Jung, J. H.; Kam, S. C.; Park, H. C.; Kim, C. W.; Kang, K. R.; Hyun, J. S.; Chung, K. H. Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis. J. Korean Med. Sci. 2005, 20 (3), 450-5.
81. Perroud, B.; Lee, J.; Valkova, N.; Dhirapong, A.; Lin, P. Y.; Fiehn, O.; Kultz, D.; Weiss, R. H. Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol. Cancer 2006, 5, 64.
82. Okamura, N.; Masuda, T.; Gotoh, A.; Shirakawa, T.; Terao, S.; Kaneko, N.; Suganuma, K.; Watanabe, M.; Matsubara, T.; Seto, R.; Matsumoto, J.; Kawakami, M.; Yamamori, M.; Nakamura, T.; Yagami, T.; Sakaeda, T.; Fujisawa, M.; Nishimura, O.; Okumura, K. Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma. Proteomics 2008, 8 (15), 3194-203.
83. Siu, K. W.; DeSouza, L. V.; Scorilas, A.; Romaschin, A. D.; Honey, R. J.; Stewart, R.; Pace, K.; Youssef, Y.; Chow, T. F.; Yousef, G. M. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. J. Proteome Res. 2009, 8 (8), 3797-807.
84. Perroud, B.; Ishimaru, T.; Borowsky, A. D.; Weiss, R. H. Gradedependent proteomics characterization of kidney cancer. Mol. Cell. Proteomics 2009, 8 (5), 971-85.
85. Lichtenfels, R.; Dressler, S. P.; Zobawa, M.; Recktenwald, C. V.; Ackermann, A.; Atkins, D.; Kersten, M.; Hesse, A.; Puttkammer, M.; Lottspeich, F.; Seliger, B. Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis. Mol. Cell. Proteomics 2009, 8 (12), 2827-42.
86. Kim, D. S.; Choi, Y. P.; Kang, S.; Gao, M. Q.; Kim, B.; Park, H. R.; Choi, Y. D.; Lim, J. B.; Na, H. J.; Kim, H. K.; Nam, Y. P.; Moon, M. H.; Yun, H. R.; Lee, D. H.; Park, W. M.; Cho, N. H. Panel of candidate biomarkers for renal cell carcinoma. J. Proteome Res. 2010, 9 (7), 3710-9.
87. Seliger, B.; Dressler, S. P.; Lichtenfels, R.; Kellner, R. Candidate biomarkers in renal cell carcinoma. Proteomics 2007, 7 (24), 4601-12.
88. Craven, R. A.; Banks, R. E. Understanding and managing renal cell carcinoma: can proteomic studies contribute to clinical practice. Contrib. Nephrol. 2008, 160, 88-106.
89. Higgins, J. P.; Shinghal, R.; Gill, H.; Reese, J. H.; Terris, M.; Cohen, R. J.; Fero, M.; Pollack, J. R.; van de Rijn, M.; Brooks, J. D. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am. J. Pathol. 2003, 162 (3), 925-32. (Pubitemid 36237499)
90. Tan, M. H.; Rogers, C. G.; Cooper, J. T.; Ditlev, J. A.; Maatman, T. J.; Yang, X.; Furge, K. A.; Teh, B. T. Gene expression profiling of renal cell carcinoma. Clin. Cancer Res. 2004, 10 (18 Pt 2), 6315S-21S. (Pubitemid 39287485)
91. Wang, E.; Lichtenfels, R.; Bukur, J.; Ngalame, Y.; Panelli, M. C.; Seliger, B.; Marincola, F. M. Ontogeny and oncogenesis balance the transcriptional profile of renal cell cancer. Cancer Res. 2004, 64 (20), 7279-87. (Pubitemid 39372065)
92. Yang, X. J.; Sugimura, J.; Schafernak, K. T.; Tretiakova, M. S.; Han, M.; Vogelzang, N. J.; Furge, K.; Teh, B. T. Classification of renal neoplasms based on molecular signatures. J. Urol. 2006, 175 (6), 2302-6. (Pubitemid 43668508)
93. Young, A. N.; Amin, M. B.; Moreno, C. S.; Lim, S. D.; Cohen, C.; Petros, J. A.; Marshall, F. F.; Neish, A. S. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am. J. Pathol. 2001, 158 (5), 1639-51. (Pubitemid 32422929)
94. Farh, K. K.; Grimson, A.; Jan, C.; Lewis, B. P.; Johnston, W. K.; Lim, L. P.; Burge, C. B.; Bartel, D. P. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 2005, 310 (5755), 1817-21. (Pubitemid 41814382)
95. Lim, L. P.; Lau, N. C.; Garrett-Engele, P.; Grimson, A.; Schelter, J. M.; Castle, J.; Bartel, D. P.; Linsley, P. S.; Johnson, J. M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433 (7027), 769-73. (Pubitemid 40292988)
96. Huang, J. C.; Babak, T.; Corson, T. W.; Chua, G.; Khan, S.; Gallie, B. L.; Hughes, T. R.; Blencowe, B. J.; Frey, B. J.; Morris, Q. D. Using expression profiling data to identify human microRNA targets. Nat. Methods 2007, 4 (12), 1045-9. (Pubitemid 350201777)
97. Margolin, A. A.; Ong, S. E.; Schenone, M.; Gould, R.; Schreiber, S. L.; Carr, S. A.; Golub, T. R. Empirical Bayes analysis of quantitative proteomics experiments. PLoS One 2009, 4 (10), e7454.
98. Yang, Y.; Chaerkady, R.; Kandasamy, K.; Huang, T. C.; Selvan, L. D.; Dwivedi, S. B.; Kent, O. A.; Mendell, J. T.; Pandey, A. Identifying targets of miR-143 using a SILAC-based proteomic approach. Mol. Biosyst. 2010, 6 (10), 1873-82.
99. Li, J.; Min, R.; Bonner, A.; Zhang, Z. A probabilistic framework to improve microrna target prediction by incorporating proteomics data. J. Bioinform. Comput. Biol. 2009, 7 (6), 955-72.
100. Selbach, M.; Schwanhausser, B.; Thierfelder, N.; Fang, Z.; Khanin, R.; Rajewsky, N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455 (7209), 58-63.
101. Diakoumis, E.; Sourvinos, G.; Kiaris, H.; Delakas, D.; Cranidis, A.; Spandidos, D. A. Genetic instability in renal cell carcinoma. Eur. Urol. 1998, 33 (2), 227-32. (Pubitemid 28073771)
102. Jiang, F.; Richter, J.; Schraml, P.; Bubendorf, L.; Gasser, T.; Sauter, G.; Mihatsch, M. J.; Moch, H. Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am. J. Pathol. 1998, 153 (5), 1467-73. (Pubitemid 28509903)
103. Klatte, T.; Rao, P. N.; de Martino, M.; LaRochelle, J.; Shuch, B.; Zomorodian, N.; Said, J.; Kabbinavar, F. F.; Belldegrun, A. S.; Pantuck, A. J. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J. Clin. Oncol. 2009, 27 (5), 746-53.
104. Kuroda, N.; Tamura, M.; Shiotsu, T.; Nakamura, S.; Taguchi, T.; Tominaga, A.; Hes, O.; Michal, M.; Kawada, C.; Shuin, T.; Lee, G. H. Chromosomal abnormalities of clear cell renal cell carcinoma: frequent gain of chromosome 7. Pathol. Int. 2010, 60 (1), 9-13.